367 related articles for article (PubMed ID: 26108897)
21. The changing approach for identifying hereditary colorectal cancer syndromes.
Laghi L; Ricciardiello L
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
[No Abstract] [Full Text] [Related]
22. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
[TBL] [Abstract][Full Text] [Related]
23. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
[TBL] [Abstract][Full Text] [Related]
24. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
[TBL] [Abstract][Full Text] [Related]
25. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
26. Next generation sequencing for disorders of sex development.
Tobias ES; McElreavey K
Endocr Dev; 2014; 27():53-62. PubMed ID: 25247644
[TBL] [Abstract][Full Text] [Related]
27. Evolving Significance of Tumor-Normal Sequencing in Cancer Care.
Mandelker D; Ceyhan-Birsoy O
Trends Cancer; 2020 Jan; 6(1):31-39. PubMed ID: 31952779
[TBL] [Abstract][Full Text] [Related]
28. Hereditary cancer testing challenges: assembling the analytical pieces to solve the patient clinical puzzle.
Bowles KR; Mancini-DiNardo D; Coffee B; Cox HC; Qian Y; Elias M; Singh N; Judkins T; Leclair B; Roa BB
Future Oncol; 2019 Jan; 15(1):65-79. PubMed ID: 30113232
[TBL] [Abstract][Full Text] [Related]
29. [Usefulness of the oncogenetic molecular counselling in adults whith familial cancer].
Valdespino-Gómez VM; Valdespino-Castillo VE
Rev Med Inst Mex Seguro Soc; 2016; 54(3):364-74. PubMed ID: 27100983
[TBL] [Abstract][Full Text] [Related]
30. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.
Kuhlen M; Borkhardt A
Eur J Pediatr; 2015 Aug; 174(8):987-97. PubMed ID: 25982339
[TBL] [Abstract][Full Text] [Related]
31. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
Bijlsma RM; Wessels H; Wouters RHP; May AM; Ausems MGEM; Voest EE; Bredenoord AL
Fam Cancer; 2018 Apr; 17(2):309-316. PubMed ID: 28852913
[TBL] [Abstract][Full Text] [Related]
32. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
33. ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing.
Lopez-Doriga A; Feliubadaló L; Menéndez M; Lopez-Doriga S; Morón-Duran FD; del Valle J; Tornero E; Montes E; Cuesta R; Campos O; Gómez C; Pineda M; González S; Moreno V; Capellá G; Lázaro C
Hum Mutat; 2014 Mar; 35(3):271-7. PubMed ID: 24227591
[TBL] [Abstract][Full Text] [Related]
34. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic methods used in diagnosis of hereditary cancers].
Patócs A
Magy Onkol; 2020 Mar; 64(1):25-31. PubMed ID: 32181759
[TBL] [Abstract][Full Text] [Related]
36. Understanding next generation sequencing in oncology: A guide for oncologists.
Moorcraft SY; Gonzalez D; Walker BA
Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases.
Santani A; Murrell J; Funke B; Yu Z; Hegde M; Mao R; Ferreira-Gonzalez A; Voelkerding KV; Weck KE
Arch Pathol Lab Med; 2017 Jun; 141(6):787-797. PubMed ID: 28322587
[TBL] [Abstract][Full Text] [Related]
38. Genetic Testing for Rare Cancer: The Wider Issues.
Jacobs C; Pichert G
Recent Results Cancer Res; 2016; 205():213-26. PubMed ID: 27075356
[TBL] [Abstract][Full Text] [Related]
39. Common hereditary cancer syndromes.
Greco KE; Mahon S
Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
[TBL] [Abstract][Full Text] [Related]
40. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.
Paulo P; Pinto P; Peixoto A; Santos C; Pinto C; Rocha P; Veiga I; Soares G; Machado C; Ramos F; Teixeira MR
J Mol Diagn; 2017 Jul; 19(4):502-513. PubMed ID: 28529006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
